Skip to main content

First peanut allergy drug gets US approval

Biopharmaceutical company Aimmune Therapeutics says the US Food and Drug Administration has approved its drug to reduce, and potentially eliminate, allergic reactions to peanuts in children aged 4 to 17 and that it had priced it at $US890 ($A1,330) per month.

from Breaking News | Daily Telegraph https://ift.tt/2S3JX5k

Comments

Popular posts from this blog

LimeWire, Former File-Sharing Service, Is Revealed as Buyer of Fyre Festival

By Sopan Deb from NYT U.S. https://ift.tt/mO53Eit

Trump Is Said to Have Known About NASA Nominee’s Donations Before Picking Him

By Maggie Haberman and Ryan Mac from NYT U.S. https://ift.tt/PKh4A5V

Tennessee Becomes Latest Republican-Led State to Send National Guard to D.C.

By Katie Glueck and Anushka Patil from NYT U.S. https://ift.tt/xMN2Own